Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics
Cell Reports · 2024-06 · 43 (6) · 114272
DOI: 10.1016/j.celrep.2024.114272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-06. Verfasst von Yun-Chien Chang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Bavaria, Germany. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Proteomics. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AstraZeneca, Deutsche Forschungsgemeinschaft, Knut och Alice Wallenbergs Stiftelse.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Bavaria, Germany.
- Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden.
- Cancer Drug Development, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany; Biosciences Faculty, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
- Chair of Proteomics and Bioanalytics, TUM School of Life Sciences, Technical University of Munich, Freising, Bavaria, Germany; Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), TUM School of Life Sciences,…
- Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden; Department of Bioengineering, Stanford University, Stanford, CA…
- Cancer Drug Development, German Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Baden-Württemberg, Germany.
Förderung
- AstraZeneca
- Deutsche Forschungsgemeinschaft
- Knut och Alice Wallenbergs Stiftelse
- European Research Council
- BMBF Bonn
Zitieren
APA
Chang, Y. C., Gnann, C., Steimbach, R. R., Bayer, F. P., Lechner, S., Sakhteman, A., Abele, M., Zecha, J., Trendel, J., The, M., Lundberg, E., Miller, A. K., & Kuster, B. (2024). Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics. Cell Reports, 43(6), 114272. https://doi.org/10.1016/j.celrep.2024.114272
Vancouver
Chang YC, Gnann C, Steimbach RR, Bayer FP, Lechner S, Sakhteman A, et al. Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics. Cell Reports. 2024;43(6):114272. doi:10.1016/j.celrep.2024.114272
BibTeX
@article{Chang2024,
author = {Chang, Yun-Chien and Gnann, Christian and Steimbach, Raphael R and Bayer, Florian P and Lechner, Severin and Sakhteman, Amirhossein and Abele, Miriam and Zecha, Jana and Trendel, Jakob and The, Matthew and Lundberg, Emma and Miller, Aubry K and Kuster, Bernhard},
title = {Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {6},
pages = {114272},
doi = {10.1016/j.celrep.2024.114272}
}
EUVIMED